February 18, 2021
Expansion plans underway at Avid's Myford North facility in Tustin
Stories this photo appears in:
Humanigen Drug to Treat Severe Immune Responses
Avid Bioservices Inc. of Tustin scored its third contract manufacturing agreement for efforts to combat COVID-19, announcing a deal this month with Burlingame-based Humanigen Inc.